Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech ...

Building a biotech startup can be a daunting task and often founders rely on incubators - but how to choose the right one?

We often focus on covering the innovation side of the biotech industry – we describe how promising investigational drugs work, what trends shape the biotech industry, and the companies within it. But ...

Bugworks, which is headquartered in the U.S. with subsidiaries in India and Australia, specializes in the development of antibiotics that could address the growing crisis of antimicrobial resistance.

The integration of artificial intelligence (AI) in the biotech industry seems boundless. Its combination with CRISPR could be the one area where AI has the most potential. Nobel prize winner and ...

Idiopathic pulmonary fibrosis (IPF) is a rare condition where the lungs become scarred, making it hard to breathe. The cause of the disease is unknown, which is why it is called ‘idiopathic.’ So far, ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

One of the biggest buyouts last month was Swiss pharma giant Roche’s $1.5 billion dollar acquisition of cell and gene therapy developer Poseida Therapeutics. This will see Roche nab the CAR-T ...